Form 4: Colgate-Palmolive Director Martin Harris Receives Stock and Option Grants

Director Martin Harris acquired 1,514 shares of common stock and options to purchase 2,272 shares of common stock from Colgate-Palmolive on May 12, 2025, as part of the company's incentive compensation plan.

Summary

• On May 12, 2025, Martin Harris, a director of Colgate-Palmolive, acquired 1,514 shares of common stock as an annual director stock grant.
• Harris also received an option to purchase 2,272 shares of common stock as an annual director stock option grant.
• The stock was acquired at a price of $0.00 per share.
• The option has an exercise price of $89.14 per share and becomes exercisable in equal annual installments over three years, starting on May 12, 2026.
• Following these transactions, Harris directly owns 22,801 shares of common stock and options to purchase 2,272 shares.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally. The grants suggest a positive outlook for the company's performance, as they incentivize the director to work towards increasing shareholder value.

Positives

• The stock and option grants are part of Colgate-Palmolive's incentive compensation plan, aligning director interests with shareholder value.
• The vesting schedule of the options encourages long-term commitment from the director.

Industry Context

Stock and option grants are a common form of executive compensation in publicly traded companies, aligning the interests of directors and shareholders. These grants incentivize directors to focus on long-term value creation.

Comparison to Industry Standards

• Colgate-Palmolive's executive compensation practices, including stock and option grants, are generally in line with those of its peers in the consumer staples industry, such as Procter & Gamble (P&G) and Unilever.
• These companies often use a mix of salary, bonus, stock options, and restricted stock units to incentivize and retain key executives and directors.
• The specific terms of the grants, such as vesting schedules and exercise prices, are typically benchmarked against industry standards to ensure competitiveness.

Stakeholder Impact

• The stock and option grants align the director's interests with those of shareholders, potentially leading to decisions that benefit shareholder value.
• The grants have no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Colgate-Palmolive, Director, Stock Grant, Stock Option, Incentive Compensation, Form 4